Company · founded 2000
MandalMed (United States)
San Francisco, United States · mandalmed.com/MandalMed_Home.shtml
- Citations, last 5 years
- 119
- Works, last 5 years
- 2
- h-index
- 31
- Scientists listed
- 0
- Grants since 2016
- 6
Grants received
2024–2026 · research · R43
Cell-based Gene Therapy for MPS IVA
Constance M John · MandalMed (United States) · funded by National Institutes of Health
2018–2021 · research · R43
Biologic Inhibitor of Galectin-3 for Liver Fibrosis
Constance M John · MandalMed (United States) · funded by National Institutes of Health
2016–2019 · research · R44
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction
Constance M John · MandalMed (United States) · funded by National Institutes of Health
2016–2017 · research · R44
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction
Constance M John · MandalMed (United States) · funded by National Institutes of Health
2016–2020 · research · R44
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction
Constance M John · MandalMed (United States) · funded by National Institutes of Health
2016–2020 · research · R44
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction Supplement
Constance M John · MandalMed (United States) · funded by National Institutes of Health
